Stocks vs Index trading: What’s the difference?

The beginning of a year is often the time when traders and investors reassess their strategies, reflecting on the gains they have made in 2021 and contemplating how the world – and stock markets – have changed. This year, much like the past two, is filled with new uncertainty and a dynamic global economic backdrop that warrants an assessment of risk profiles, and one that will often come down to a key question: Is it better to buy indices or specific stocks?

Fastly (FSLY) stock forecast: Is the comeback on?

Fastly (FSLY) has had a difficult year in 2021, with shares falling on the back of underwhelming earnings reports. Yet after the recent acquisition of Signal Sciences, can the computing services provider get back on track towards its 2025 $1bn revenue target, and what factors are shaping FSLY stock forecast this year? Fastly is a cloud computing service. It debuted on the NYSE in May 2019 through an initial public offering (IPO) priced at $16.00 a share. Fastly experienced a year to forget in

Cortexyme (CRTX) stock forecast: Can the drug maker recover?

Uncertainty abounds for Cortexyme (CRTX). Will a disappointing end to October have a lasting impact on the company? The stock lost more than three quarters of its value following the failure of the Atuzaginstat drug in a Phase 3 trial. The price has since treaded water, with gains erased as quickly as they are added in the last two months. Can the stock recover? What factors are shaping the Cortexyme share price forecast?

Saga share price forecast: Is an Indian Summer on the horizon for over-50s provider?

Saga is a company focused on over-50s, offering holidays, cruise journeys, insurance and money services. It floated on the LSE in 2014. The stock enters the second half of 2021 tentatively poised on a recovering global travel industry and its own comeback from internal company turmoil. The group has fallen considerably since its peak share price in 2016, but is set to enter 2022 with bullish potential.
Load More Articles
Close